962 resultados para 129-801
Resumo:
Using the slow highly charged ions Xe-129(q+) (q = 25, 26, 27; initial kinetic T-0 <= 4.65 keV/a.u.) to impact Au surface, the Au atomic M alpha characteristic X-ray spectrum is induced. The result shows that as long as the charge state of projectile is high enough, the heavy atomic characteristic X-ray can be effectively excited even though the incident beam is very weak (nA magnitude), and the X-ray yield per ion is in the order of 10(-8) and increases with the kinetic energy and potential energy of projectile. By measuring the Au M alpha-X-ray spectra, Au atomic N-level lifetime is estimated at about 1.33x10(-18) s based on Heisenberg uncertainty relation.
Resumo:
Nd-129 was produced by irradiation of an enriched target of Ru-96 with a Ar-36 beam and studied by using a helium-jet fast tape transport system in combination with X-gamma and gamma-gamma coincidence measurements. A 2.6s isomer of Nd-129 was observed for the first time and tentatively proposed to be the configuration of 1/2[411].
Resumo:
We studied the characteristic X-ray spectra produced by the interaction of highly charged ions of X-129(q+) (q =25, 26, 27) with surface of metallic Mo. The experimental result shows that highly charged ions can excite the characteristic X-ray spectra of L-shell of Mo when the beam' s intensity is not more than 120 nA. The X-ray yield of single ion reaches a quantitative level of 10(-8) and increases with the increment of the ion' s kinetic energy and ionic charge (potential energy). By measuring the X-ray spectra of Mo-L alpha(1) the M-level lifetime of Mo atom is estimated by using Heisenberg uncertainty relation.
Resumo:
研究了高电荷态离子129Xeq+(q=25,26,27)入射金属Mo表面产生的特征X射线谱.实验结果表明,在束流强度小于120nA条件下,高电荷态离子129Xeq+可以激发Mo的L壳层特征X射线谱.单离子X射线相对产额可达10-8量级,特征X射线的相对产额随入射离子的动能和电荷态(势能)的增加而增加.通过Mo原子的Lα1特征X射线谱,利用Heisenberg不确定关系对Mo原子的第M能级寿命进行了估算.
Resumo:
采用微生物菌落计数方法和Pearson相关性分析,以辽河油田锦采污水处理厂稠油废水为对象,研究了不同季节稠油废水中优势微生物的种群组成及其变化规律。结果表明,在稠油废水处理过程中微生物种群组成及其作用均以细菌为主,真菌次之,放线菌最小;细菌菌落形态多样性指数(H′)与均匀度指数(E)均能较准确地反映废水中的细菌多样性,但不能反映水质状况,不宜作为该水质评价的生物指标;细菌数量与总石油烃(TPH)和COD均呈强正相关,统计学上关系显著,适宜作为废水水质评价的生物指标;经鉴定,废水中的优势菌株为液化金杆菌(Aureobateriumliquefaciens)和弗氏丙酸杆菌(Propionibacterium freudenreichii),主要真菌为青霉属(Penicillium)、曲霉属(Aspergillus)、木霉属(Trichoderma)和交链孢霉属(Alternaria)。
Resumo:
为了定量分析和比较区域生态服务功能及其价值变化,运用中国生态系统服务价值当量因子表和岷江上游流域单位面积农田生态系统提供的食物生产服务的经济价值,以及分析1986、1995和2000年三期TM遥感影像所得到的土地利用情况,对岷江上游地区不同年代的生态服务价值变化进行了估算和比较。并初步分析了生态服务价值变化的原因。1986~1995年,农田面积增加了60 801 hm2,比1986年增长了477%。林地面积减少了89 012.17 hm2,占原来面积的4.97%。总的生态服务价值从1986年到2000年减少了119.9×108元。主要是由于人口的增加和森林的砍伐,导致森林面积减少,转变为草地、农田等土地利用类型。通过1995年和2000年对比得出:自从1998年实施"天然林保护工程"政策以来,到2000年森林生态系统面积与1995年相差约4 165.28 hm2,生态服务价值相差约7.9亿元,可见国家政策在保护生态系统服务功能上虽起到了一定的作用,但与1986年相比还相差甚远,天然林保护工程任重而道远。
Resumo:
目的研究文冠果果壳乙醇提取物、总皂苷及ST-n-2对学习记忆障碍的影响,并初步探讨其作用机制。方法采用跳台法观察东莨菪碱和亚硝酸钠所致学习记忆障碍小鼠的学习记忆能力,八臂放射状迷路法观察(+)-MK-801致学习记忆障碍大鼠的学习记忆能力。结果文冠果果壳乙醇提取物、总皂苷及ST-n-2均显著改善东莨菪碱所致的记忆获得障碍和亚硝酸钠所致的记忆巩固障碍,文冠果果壳乙醇提取物显著改善(+)-MK-801所致的工作记忆和参照记忆障碍。结论文冠果果壳乙醇提取物、总皂苷及ST-n-2对学习记忆障碍均有显著改善作用,其作用机制可能与增强中枢胆碱能神经系统及谷氨酸能神经系统功能、抗脑组织耗氧损伤有关;总皂苷是文冠果果壳改善记忆障碍的有效部位,ST-n-2是其主要有效成分之一。
Resumo:
探讨了外源NO对水分胁迫下杨树叶片质膜相对透性、叶片光合作用和氧化伤害保护酶的影响.结果表明,NO供体硝普钠(sodiumnitroprusside,SNP)能提高杨树叶片的含水率,在水分胁迫(PEG6000渗透液处理)下,能缓解叶片的水分丢失.NO对杨树叶片光合作用具有双重性,低浓度SNP(200、500μmol·L-1)能促进叶片的光合,高浓度SNP(1000、2000μmol·L-1)则明显抑制叶片的光合.较短时间水分处理胁迫(1h))的杨树叶片SOD和POD活性显著高于较长时间(3h)水分胁迫下叶片的酶活性.经SNP处理后,各处理组POD、SOD活性明显上升.同时,随SNP浓度的增加,POD和SOD活性表现出先上升后下降的趋势.外源NO可通过诱导POD和SOD活性的上升,延缓活性氧的积累,从而减轻水分胁迫对杨树的伤害,增强树木的耐旱能力.
Resumo:
仲氏针层孔菌和假斑点嗜蓝孢孔菌为中国孔状木生真菌2新记录种。本文根据采集的标本材料提供了该2个种的详细描述和线条图。
Resumo:
The transfer of H+, Li+, Na+, Zn2+, Mg2+ and Cu2+ facilitated by ionophore ETH 129 (N, N, N', N'-tetracyolohexyl-3-oxapentanediamide) across water/nitrobenzene interface has been studied by the cyclic voltammetry. The mechanism of the transfer process has been discussed. The diffusion coefficients and the stability constants of the complexes formed in the nitrobenzene phase have been determined.
Resumo:
2004
Resumo:
T cell immune responses to central nervous system-derived and other self-antigens are commonly described in both healthy and autoimmune individuals. However, in the case of the human prion protein (PrP), it has been argued that immunologic tolerance is uncommonly robust. Although development of an effective vaccine for prion disease requires breaking of tolerance to PrP, the extent of immune tolerance to PrP and the identity of immunodominant regions of the protein have not previously been determined in humans. We analyzed PrP T cell epitopes both by using a predictive algorithm and by measuring functional immune responses from healthy donors. Interestingly, clusters of epitopes were focused around the area of the polymorphic residue 129, previously identified as an indicator of susceptibility to prion disease, and in the C-terminal region. Moreover, responses were seen to PrP peptide 121-134 containing methionine at position 129, whereas PrP 121-134 [129V] was not immunogenic. The residue 129 polymorphism was also associated with distinct patterns of cytokine response: PrP 128-141 [129M] inducing IL-4 and IL-6 production, which was not seen in response to PrP 128-141 [129V]. Our data suggest that the immunogenic regions of human PrP lie between residue 107 and the C-terminus and that, like with many other central nervous system antigens, healthy individuals carry responses to PrP within the T cell repertoire and yet do not experience deleterious autoimmune reactions.
Resumo:
Background: After breast-conserving surgery, radiotherapy reduces recurrence and breast cancer death, but it may do so more for some groups of women than for others. We describe the absolute magnitude of these reductions according to various prognostic and other patient characteristics, and relate the absolute reduction in 15-year risk of breast cancer death to the absolute reduction in 10-year recurrence risk.
Methods: We undertook a meta-analysis of individual patient data for 10?801 women in 17 randomised trials of radiotherapy versus no radiotherapy after breast-conserving surgery, 8337 of whom had pathologically confirmed node-negative (pN0) or node-positive (pN+) disease.
Findings: Overall, radiotherapy reduced the 10-year risk of any (ie, locoregional or distant) first recurrence from 35·0% to 19·3% (absolute reduction 15·7%, 95% CI 13·7–17·7, 2p<0·00001) and reduced the 15-year risk of breast cancer death from 25·2% to 21·4% (absolute reduction 3·8%, 1·6–6·0, 2p=0·00005). In women with pN0 disease (n=7287), radiotherapy reduced these risks from 31·0% to 15·6% (absolute recurrence reduction 15·4%, 13·2–17·6, 2p<0·00001) and from 20·5% to 17·2% (absolute mortality reduction 3·3%, 0·8–5·8, 2p=0·005), respectively. In these women with pN0 disease, the absolute recurrence reduction varied according to age, grade, oestrogen-receptor status, tamoxifen use, and extent of surgery, and these characteristics were used to predict large (=20%), intermediate (10–19%), or lower (<10%) absolute reductions in the 10-year recurrence risk. Absolute reductions in 15-year risk of breast cancer death in these three prediction categories were 7·8% (95% CI 3·1–12·5), 1·1% (–2·0 to 4·2), and 0·1% (–7·5 to 7·7) respectively (trend in absolute mortality reduction 2p=0·03). In the few women with pN+ disease (n=1050), radiotherapy reduced the 10-year recurrence risk from 63·7% to 42·5% (absolute reduction 21·2%, 95% CI 14·5–27·9, 2p<0·00001) and the 15-year risk of breast cancer death from 51·3% to 42·8% (absolute reduction 8·5%, 1·8–15·2, 2p=0·01). Overall, about one breast cancer death was avoided by year 15 for every four recurrences avoided by year 10, and the mortality reduction did not differ significantly from this overall relationship in any of the three prediction categories for pN0 disease or for pN+ disease.
Interpretation: After breast-conserving surgery, radiotherapy to the conserved breast halves the rate at which the disease recurs and reduces the breast cancer death rate by about a sixth. These proportional benefits vary little between different groups of women. By contrast, the absolute benefits from radiotherapy vary substantially according to the characteristics of the patient and they can be predicted at the time when treatment decisions need to be made.
Funding: Cancer Research UK, British Heart Foundation, and UK Medical Research Council.